Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 900 of 542236 entries
View as:

Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06092450 Org: User:
Start: 08/01/23 End: 06/01/25 Due: 06/01/26

A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05590377 Org: User:
Start: 01/26/23 End: 05/22/24 Due: 05/22/25

Effect of BTL-899 Device for Non-invasive Lipolysis on Human Upper Arms

Phase: N/A Priority: Normal
NCT ID: NCT04643275 Org: User:
Start: 10/15/20 End: 09/02/21 Due: 09/02/22

MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial

Phase: N/A Priority: Normal
NCT ID: NCT02306330 Org: User:
Start: 12/31/14 End: 01/31/16 Due: 01/31/17

Platelet-activation and Optimal Inhibition in Patients With Atrial Fibrillation Undergoing Left Atrial Appendage Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT04705688 Org: User:
Start: 02/24/21 End: 12/31/24 Due: 12/31/25

Healthynsect Child Growth and Health Intervention Study

Phase: N/A Priority: Normal
NCT ID: NCT06002620 Org: User:
Start: 03/09/23 End: 01/16/24 Due: 01/16/25

The Role of Endothelin-1 in Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT02712346 Org: User:
Start: 09/30/15 End: 11/30/19 Due: 11/30/20

Suitability of DCE-MRI for Detection of Vascular Changes After VBT

Phase: N/A Priority: Normal
NCT ID: NCT01991808 Org: User:
Start: 10/31/13 End: 12/08/16 Due: 12/08/17

Modified Vagus Nerve-preserving Laparoscopic Splenectomy and Azygoportal Disconnection

Phase: N/A Priority: Normal
NCT ID: NCT03396796 Org: User:
Start: 04/09/18 End: 12/31/19 Due: 12/31/20

Safety and Efficacy Study of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Alagille Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01903460 Org: User:
Start: 08/31/13 End: 03/31/15 Due: 03/31/16

Wear and Migration in the Corin Mini-Hip/Metafix and ECIMA Polyethylene

Phase: N/A Priority: Normal
NCT ID: NCT02174965 Org: User:
Start: 09/30/12 End: 09/30/22 Due: 09/30/23

Tranexamic Acid in Chinese Elderly Patients With Intertrochanteric Fracture RCT

Phase: N/A Priority: Normal
NCT ID: NCT04290884 Org: User:
Start: 05/23/18 End: 05/31/20 Due: 05/31/21

mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02028806 Org: User:
Start: 02/28/13 End: 12/31/20 Due: 12/31/21

Feasibility Tests for Various Prism Configurations for Visual Field Loss

Phase: N/A Priority: Normal
NCT ID: NCT04424979 Org: User:
Start: 11/06/20 End: 08/31/25 Due: 08/31/26

Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings

Phase: N/A Priority: Normal
NCT ID: NCT06151158 Org: User:
Start: 03/10/25 End: 10/14/28 Due: 10/14/29

Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures

Phase: N/A Priority: Normal
NCT ID: NCT06579989 Org: User:
Start: 01/31/26 End: 01/31/28 Due: 01/31/29

Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT04720326 Org: User:
Start: 12/23/20 End: 10/31/26 Due: 10/31/27

Comparative Effectiveness of Diabetes Shared Medical Appointment Models

Phase: N/A Priority: Normal
NCT ID: NCT03590041 Org: User:
Start: 01/04/19 End: 12/31/22 Due: 12/31/23

Feasibility Trial of Glofitamab in a Response Adapted Approach Incorporating Interim FDG PET and ctDNA to Optimize Primary Therapy of DLBCL (GRAIL)

Phase: N/A Priority: Normal
NCT ID: NCT06050694 Org: User:
Start: 01/24/25 End: 11/30/27 Due: 11/30/28

Pirfenidone LP or Collagen-polyvinylpyrrolidone in COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT06585319 Org: User:
Start: 02/01/20 End: 08/31/24 Due: 08/31/25

Advanced Care Planning for the Severely Ill Home-dwelling Elderly

Phase: N/A Priority: Normal
NCT ID: NCT05681585 Org: User:
Start: 10/18/23 End: 12/31/26 Due: 12/31/27

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Phase: N/A Priority: Normal
NCT ID: NCT05488431 Org: User:
Start: 03/01/23 End: 03/01/28 Due: 03/01/29

Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation

Phase: N/A Priority: Normal
NCT ID: NCT04788888 Org: User:
Start: 06/13/21 End: 02/28/36 Due: 02/28/37

A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)

Phase: N/A Priority: Normal
NCT ID: NCT05673928 Org: User:
Start: 05/16/23 End: 03/01/29 Due: 03/01/30

Study Evaluating the Efficacy and Safety of BENEV Exosome Regenerative Complex+ for Self-perceived Thinning Hair

Phase: N/A Priority: Normal
NCT ID: NCT06571799 Org: User:
Start: 09/03/24 End: 03/27/25 Due: 03/27/26